Sign inGet started

Merck & Co., Inc.

Insider CIK 310158 · OPGN 10% owner · STRO 10% owner · NGM 10% owner · BGNE 10% owner · HARP 10% owner · ORG 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HARP Harpoon Therapeutics, Inc. P Buy2024-03-112024-03-1121,397,205$23.00 $492.14M1,000SEC↗
ORG Organon & Co. J Other2021-06-022021-06-04253,516,000— $00SEC↗
NGM NGM BIOPHARMACEUTICALS INC C Conversion deriv2019-04-082019-04-0917,666,666— $00SEC↗
NGM NGM BIOPHARMACEUTICALS INC C Conversion2019-04-082019-04-098,833,333— $08,833,333SEC↗
NGM NGM BIOPHARMACEUTICALS INC P Buy2019-04-082019-04-094,121,683$16.00 $65.95M12,955,016SEC↗
STRO SUTRO BIOPHARMA INC C Conversion deriv2018-10-012018-10-0274,794,315— $00SEC↗
STRO SUTRO BIOPHARMA INC C Conversion2018-10-012018-10-022,056,843— $02,056,843SEC↗
STRO SUTRO BIOPHARMA INC P Buy2018-10-012018-10-02666,666$15.00 $10.00M2,723,509SEC↗
OPGN OPGEN INC P Buy deriv2016-06-272016-06-292,050,821— $02,950,821SEC↗
OPGN OPGEN INC A Award2016-06-272016-06-292,734,427— $05,413,449SEC↗
OPGN OPGEN INC P Buy deriv2016-05-192016-05-24900,000— $0900,000SEC↗
OPGN OPGEN INC P Buy deriv2016-05-192016-05-242,734,427— $05,685,248SEC↗
OPGN OPGEN INC A Award2016-05-192016-05-241,200,000— $02,679,022SEC↗
BGNE BeiGene, Ltd. C Conversion deriv2016-02-082016-02-1018,518,519— $00SEC↗
BGNE BeiGene, Ltd. C Conversion deriv2016-02-082016-02-105,128,205— $00SEC↗
BGNE BeiGene, Ltd. C Conversion2016-02-082016-02-105,128,205— $05,128,205SEC↗
BGNE BeiGene, Ltd. C Conversion2016-02-082016-02-1018,518,519— $018,518,519SEC↗
BGNE BeiGene, Ltd. J Other2016-02-082016-02-107,942,314— $07,942,314SEC↗